[HTML][HTML] Antiparkinsonian agents in investigational polymeric micro-and Nano-Systems
N Paccione, M Rahmani, E Barcia, S Negro - Pharmaceutics, 2022 - mdpi.com
Parkinson's disease (PD) is a devastating neurodegenerative disease characterized by
progressive destruction of dopaminergic tissue in the central nervous system (CNS). To …
progressive destruction of dopaminergic tissue in the central nervous system (CNS). To …
Antiparkinsonian Agents in Investigational Polymeric Micro-and Nano-Systems
N Paccione, M Rahmani, E Barcia… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Parkinson's disease (PD) is a devastating neurodegenerative disease characterized by
progressive destruction of dopaminergic tissue in the central nervous system (CNS). To …
progressive destruction of dopaminergic tissue in the central nervous system (CNS). To …
Antiparkinsonian Agents in Investigational Polymeric Micro-and Nano-Systems
N Paccione, M Rahmani, E Barcia, S Negro - Pharmaceutics, 2023 - search.proquest.com
Parkinson's disease (PD) is a devastating neurodegenerative disease characterized by
progressive destruction of dopaminergic tissue in the central nervous system (CNS). To …
progressive destruction of dopaminergic tissue in the central nervous system (CNS). To …
[HTML][HTML] Antiparkinsonian Agents in Investigational Polymeric Micro-and Nano-Systems
N Paccione, M Rahmani, E Barcia, S Negro - Pharmaceutics, 2023 - ncbi.nlm.nih.gov
Parkinson's disease (PD) is a devastating neurodegenerative disease characterized by
progressive destruction of dopaminergic tissue in the central nervous system (CNS). To …
progressive destruction of dopaminergic tissue in the central nervous system (CNS). To …
Antiparkinsonian Agents in Investigational Polymeric Micro-and Nano-Systems.
N Paccione, M Rahmani, E Barcia, S Negro - Pharmaceutics, 2022 - europepmc.org
Parkinson's disease (PD) is a devastating neurodegenerative disease characterized by
progressive destruction of dopaminergic tissue in the central nervous system (CNS). To …
progressive destruction of dopaminergic tissue in the central nervous system (CNS). To …
Antiparkinsonian Agents in Investigational Polymeric Micro-and Nano-Systems.
N Paccione, M Rahmani, E Barcia, S Negro - Pharmaceutics, 2023 - search.ebscohost.com
Parkinson's disease (PD) is a devastating neurodegenerative disease characterized by
progressive destruction of dopaminergic tissue in the central nervous system (CNS). To …
progressive destruction of dopaminergic tissue in the central nervous system (CNS). To …